Beryl Drugs Limited (BOM:524606)

Beryl Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 29, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	89	149	62	53	34	19
Market Cap Growth	63.50%	141.20%	16.36%	58.09%	81.10%	-56.34%
Enterprise Value	132	194	106	85	72	53
Last Close Price	17.48	29.33	12.16	10.45	6.61	3.65
PE Ratio	111.28	19.35	8.05	-	13.99	38.61
PS Ratio	0.44	0.56	0.23	0.36	0.24	0.14
PB Ratio	0.95	1.67	0.77	0.73	0.42	0.24
P/TBV Ratio	0.95	1.67	0.77	0.73	0.42	0.24
P/FCF Ratio	-	-	7.45	-	-	-
P/OCF Ratio	-	18.14	2.58	-	9.90	10.02
EV/Sales Ratio	0.66	0.73	0.40	0.58	0.51	0.41
EV/EBITDA Ratio	5.54	7.34	4.77	15.35	4.43	4.69
EV/EBIT Ratio	14.75	13.43	7.52	-	20.77	11.41
EV/FCF Ratio	-	-	12.81	-	-	-
Debt / Equity Ratio	0.49	0.57	0.56	0.73	0.65	0.69
Debt / EBITDA Ratio	1.90	1.93	2.04	9.60	3.17	4.67
Debt / FCF Ratio	-	-	5.49	-	-	-
Asset Turnover	-	1.53	1.52	0.80	0.79	0.81
Inventory Turnover	-	9.72	7.24	3.27	4.44	7.10
Quick Ratio	-	1.36	1.25	0.79	0.85	0.88
Current Ratio	-	1.78	1.64	1.24	1.24	1.13
Return on Equity (ROE)	-	9.05%	9.97%	-8.66%	3.08%	0.63%
Return on Assets (ROA)	-	5.16%	4.99%	-1.83%	1.21%	1.83%
Return on Capital (ROIC)	4.03%	6.78%	7.00%	-2.61%	1.66%	2.44%
Return on Capital Employed (ROCE)	-	12.30%	12.60%	-	3.30%	4.50%
Earnings Yield	0.90%	5.17%	12.42%	-12.43%	7.15%	2.59%
FCF Yield	-	-3.57%	13.42%	-16.68%	-39.77%	-91.32%
Buyback Yield / Dilution	0.05%	-	-	0.01%	-0.01%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.